Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| EXEL - Exelixis | 3.96% | Reduce −7.8% | 23,439,500 | $33.30 | $781M | −1,971,000 | +$121M |
| UNH - Unitedhealth Group | 3.75% | Add +33.2% | 1,462,500 | $505.86 | $740M | +364,600 | +$98M |
| NTRA - Natera | 3.56% | Reduce −2.8% | 4,431,609 | $158.30 | $702M | −125,700 | +$123M |
| MSFT - Microsoft | 3.49% | Add +11.3% | 1,633,147 | $421.50 | $688M | +166,400 | +$57M |
| AON - AON PLC · CL A | 3.34% | Add +7.4% | 1,832,733 | $359.16 | $658M | +126,733 | +$68M |
| TMO - Thermo Fisher Scientific | 3.25% | Add +73.8% | 1,233,256 | $520.23 | $642M | +523,800 | +$203M |
| IQV - IQVIA | 3.11% | Reduce −1.5% | 3,123,151 | $196.51 | $614M | −47,932 | −$138M |
| RVMD - Revolution Medicines | 2.94% | Add +17.1% | 13,248,692 | $43.74 | $579M | +1,931,000 | +$66M |
| ADSK - Autodesk | 2.76% | New | 1,841,800 | $295.57 | $544M | +1,841,800 | +$544M |
| TRU - Transunion | 2.50% | Reduce −2.7% | 5,326,319 | $92.71 | $494M | −149,000 | −$79M |
| DIS - Disney Walt | 2.50% | Reduce −24.0% | 4,428,068 | $111.35 | $493M | −1,401,500 | −$68M |
| LNTH - Lantheus | 2.41% | Add +79.9% | 5,316,227 | $89.46 | $476M | +2,361,000 | +$151M |
| INTU - Intuit | 2.40% | Add +19.5% | 753,758 | $628.50 | $474M | +123,061 | +$82M |
| BSX - Boston Scientific | 2.28% | Reduce −7.4% | 5,022,957 | $89.32 | $449M | −402,700 | −$6M |
| ARMK - Aramark | 2.16% | Reduce −1.9% | 11,410,340 | $37.31 | $426M | −226,597 | −$25M |
| CRM - Salesforce | 2.05% | Reduce −40.8% | 1,210,138 | $334.33 | $405M | −834,800 | −$155M |
| GOOG - Alphabet · CL C | 2.01% | Reduce −13.7% | 2,080,540 | $190.44 | $396M | −330,000 | −$7M |
| GBTC - Ishares Bitcoin Trust ETF | 1.95% | Add +404.1% | 7,259,100 | $53.05 | $385M | +5,819,100 | +$333M |
| NYT - New York Times · CL A | 1.95% | Reduce −15.7% | 7,376,113 | $52.05 | $384M | −1,368,733 | −$103M |
| Sarepta Therapeutics | 1.77% | Add +11.1% | 2,865,100 | $121.59 | $348M | +285,100 | +$26M |
| MCK - Mckesson | 1.77% | New | 610,700 | $569.91 | $348M | +610,700 | +$348M |
| ABNB - Airbnb · CL A | 1.62% | Add +2.4% | 2,429,200 | $131.41 | $319M | +58,000 | +$19M |
| NDAQ - Nasdaq | 1.57% | Add +6.3% | 3,998,019 | $77.31 | $309M | +235,748 | +$34M |
| CBRE - CBRE Group · CL A | 1.45% | Reduce −26.6% | 2,179,800 | $131.29 | $286M | −790,600 | −$84M |
| WAB - Wabtec | 1.38% | Reduce −35.3% | 1,430,198 | $189.59 | $271M | −781,200 | −$131M |
| WWD - Woodward | 1.28% | Add +31.8% | 1,521,300 | $166.42 | $253M | +367,300 | +$55M |
| ADI - Analog Devices | 1.25% | Reduce −21.4% | 1,157,200 | $212.46 | $246M | −314,900 | −$93M |
| SCHW - Schwab Charles | 1.19% | New | 3,169,000 | $74.01 | $235M | +3,169,000 | +$235M |
| PTGX - Protagonist Therapeutics | 1.16% | Add +1.2% | 5,930,006 | $38.60 | $229M | +69,000 | −$35M |
| CRNX — | 1.06% | Add +250.7% | 4,075,098 | $51.13 | $208M | +2,913,098 | +$149M |
| BEAM - Beam Therapeutics | 1.04% | Add +0.4% | 8,239,123 | $24.80 | $204M | +31,000 | +$3M |
| HIMS - Hims & Hers Health · CL A | 1.03% | Add +64338.5% | 8,377,000 | $24.18 | $203M | +8,364,000 | +$202M |
| AGIO - Agios Pharmaceuticals | 0.95% | Add +0.2% | 5,674,466 | $32.86 | $186M | +13,600 | −$65M |
| BMY - Bristol-Myers Squibb | 0.91% | New | 3,188,000 | $56.56 | $180M | +3,188,000 | +$180M |
| YMM - Full Truck Alliance | 0.91% | Reduce −19.7% | 16,585,095 | $10.82 | $179M | −4,080,453 | −$7M |
| V - VISA · CL A | 0.88% | Reduce −26.9% | 549,510 | $316.04 | $174M | −202,500 | −$33M |
| BHVN - Biohaven | 0.84% | Add +21.6% | 4,428,167 | $37.35 | $165M | +785,578 | −$17M |
| MA - Mastercard · CL A | 0.79% | Reduce −41.6% | 295,671 | $526.57 | $156M | −211,000 | −$95M |
| EDU — | 0.77% | Reduce −6.9% | 2,359,150 | $64.18 | $151M | −174,450 | −$41M |
| BBIO - Bridgebio Pharma | 0.58% | Add +140.1% | 4,195,000 | $27.44 | $115M | +2,448,000 | +$71M |
| Masimo | 0.33% | Reduce −68.5% | 397,000 | $165.30 | $66M | −861,563 | −$102M |
| CNTA - Centessa Pharmaceuticals | 0.30% | Add +24.3% | 3,498,709 | $16.75 | $59M | +684,391 | +$14M |
| HR - Healthcare Rlty Tr · CL A | 0.28% | Add +25.4% | 3,264,000 | $16.95 | $55M | +661,000 | +$8M |
| WAY - Waystar | 0.25% | New | 1,342,000 | $36.70 | $49M | +1,342,000 | +$49M |
| SPY - Spdr S&P 500 ETF Tr | 0.24% | New | 82,000 | $586.08 | $48M | +82,000 | +$48M |
| EHC - Encompass Health | 0.22% | Add +15266.7% | 461,000 | $92.35 | $43M | +458,000 | +$42M |
| LQDA - Liquidia | 0.20% | Hold | 3,290,956 | $11.76 | $39M | — | — |
| GDS — | 0.18% | Hold | 1,531,133 | $23.76 | $36M | — | — |
| TECX - Tectonic Therapeutic | 0.17% | Add +37.0% | 713,050 | $46.17 | $33M | +192,653 | +$17M |
| CAPR - Capricor Therapeutics | 0.16% | New | 2,250,400 | $13.80 | $31M | +2,250,400 | +$31M |
| FLUT - Flutter Entmt | 0.12% | Add +69.5% | 90,300 | $258.45 | $23M | +37,030 | +$11M |
| SIMO - Silicon Motion Technology | 0.11% | Reduce −19.3% | 415,000 | $54.05 | $22M | −99,000 | −$9M |
| GXO - Gxo Logistics | 0.11% | New | 513,400 | $43.50 | $22M | +513,400 | +$22M |
| Savara | 0.11% | Add +49.9% | 6,835,000 | $3.07 | $21M | +2,275,000 | +$2M |
| Zymeworks | 0.10% | Reduce −2.3% | 1,329,974 | $14.64 | $19M | −31,026 | +$2M |
| Latam Airlines Group SA | 0.09% | Add +105.9% | 618,469 | $27.58 | $17M | +318,092 | +$9M |
| WGS - Genedx · CL A | 0.08% | New | 195,000 | $76.86 | $15M | +195,000 | +$15M |
| VYGR - Voyager Therapeutics | 0.07% | Add +12.2% | 2,570,700 | $5.67 | $15M | +278,700 | +$1M |
| TYRA - Tyra Biosciences | 0.07% | New | 1,000,981 | $13.90 | $14M | +1,000,981 | +$14M |
| TNGX - Tango Therapeutics | 0.06% | New | 4,000,000 | $3.09 | $12M | +4,000,000 | +$12M |
| ENTA - Enanta Pharmaceuticals | 0.06% | Hold | 2,108,262 | $5.75 | $12M | — | — |
| ARWR - Arrowhead Pharmaceuticals | 0.06% | New | 628,800 | $18.80 | $12M | +628,800 | +$12M |
| NUVL - Nuvalent | 0.06% | Hold | 150,000 | $78.28 | $12M | — | — |
| GEHC - GE HealthCare | 0.05% | New | 124,000 | $78.18 | $10M | +124,000 | +$10M |
| MARA | 0.05% | New | 555,000 | $16.77 | $9M | +555,000 | +$9M |
| Helix Acquisition Ii · CL A | 0.03% | Hold | 600,000 | $10.50 | $6M | — | — |
| Biodesix | 0.03% | Reduce −17.8% | 3,811,426 | $1.53 | $6M | −825,365 | −$2M |
| DYN - Dyne Therapeutics | 0.03% | Reduce −46.5% | 229,121 | $23.56 | $5M | −198,879 | −$10M |
| SLNOEUR - Soleno Therapeutics | 0.02% | New | 90,000 | $44.95 | $4M | +90,000 | +$4M |
| Mac Copper | 0.02% | Reduce −19.3% | 330,901 | $10.62 | $4M | −79,296 | −$2M |
| VNET - VNET Group | 0.02% | Hold | 650,000 | $4.74 | $3M | — | — |
| ALVO - Alvotech | 0.01% | Hold | 199,675 | $13.23 | $3M | — | — |
| Janux Therapeutics | 0.01% | New | 48,000 | $53.54 | $3M | +48,000 | +$3M |
| SMC - Summit Midstream | 0.01% | Hold | 58,214 | $37.78 | $2M | — | — |
| PRME - Prime Medicine | 0.01% | Hold | 750,000 | $2.92 | $2M | — | — |
| Elevation Oncology | 0.01% | Hold | 3,527,482 | $0.5626 | $2M | — | — |
| Marblegate Acquisition · CL A | 0.01% | Hold | 150,000 | $10.99 | $2M | — | — |
| MDGL - Madrigal Pharmaceuticals | 0.01% | Hold | 3,319 | $308.57 | $1M | — | — |
| Forte Biosciences | 0.00% | Reduce −51.7% | 35,000 | $22.71 | $795K | −37,413 | +$389K |
| ROIV - Roivant Sciences | 0.00% | Hold | 37,000 | $11.83 | $438K | — | — |
| GKOS - Glaukos | 0.00% | Hold | 2,600 | $149.94 | $390K | — | — |
| BTSG - Brightspring Health Svcs | 0.00% | Hold | 22,000 | $17.03 | $375K | — | — |
| ARQT - Arcutis Biotrapeutics | 0.00% | Hold | 26,000 | $13.93 | $362K | — | — |
| TWST - Twist Bioscience | 0.00% | Reduce −97.8% | 7,650 | $46.47 | $355K | −333,000 | −$15M |
| UTHR - United Therapeutics | 0.00% | Hold | 1,000 | $352.84 | $353K | — | — |
| Blueprint Medicines | 0.00% | Hold | 4,000 | $87.22 | $349K | — | — |
| AXSM - Axsome Therapeutics | 0.00% | Hold | 4,000 | $84.61 | $338K | — | — |
| KRYS - Krystal Biotech | 0.00% | Hold | 2,000 | $156.66 | $313K | — | — |
| PGNY - Progyny | 0.00% | Reduce −98.1% | 18,000 | $17.25 | $311K | −913,307 | −$15M |
| ACLXGBX - Arcellx | 0.00% | Hold | 4,000 | $76.69 | $307K | — | — |
| HCA - Hca Healthcare | 0.00% | Hold | 1,000 | $300.15 | $300K | — | — |
| GMED - Globus Med · CL A | 0.00% | Hold | 3,600 | $82.71 | $298K | — | — |
| IMVT - Immunovant | 0.00% | Hold | 12,000 | $24.77 | $297K | — | — |
| BRKR - Bruker | 0.00% | Reduce −84.4% | 5,000 | $58.62 | $293K | −27,000 | −$2M |
| MMSI - Merit Med Sys | 0.00% | Hold | 3,000 | $96.72 | $290K | — | — |
| HQY - Healthequity | 0.00% | Hold | 2,800 | $95.95 | $269K | — | — |
| PACB — | 0.00% | Hold | 135,000 | $1.83 | $247K | — | — |
| SBRA - Sabra Health Care Reit | 0.00% | Hold | 14,000 | $17.32 | $242K | — | — |
| Sage Therapeutics | 0.00% | Hold | 42,800 | $5.43 | $232K | — | — |
| COR - Cencora | 0.00% | Reduce −99.6% | 1,000 | $224.68 | $225K | −234,200 | −$53M |
| Icu Med | 0.00% | Hold | 1,400 | $155.17 | $217K | — | — |
| CHE - Chemed | 0.00% | Hold | 400 | $529.80 | $212K | — | — |
| ICLR - ICON | 0.00% | Reduce −99.5% | 1,000 | $209.71 | $210K | −219,800 | −$63M |
| GRFS - Grifols S A | 0.00% | Hold | 28,000 | $7.44 | $208K | — | — |
| INSM - Insmed | 0.00% | Hold | 3,000 | $69.04 | $207K | — | — |
| ONC - Beigene | 0.00% | Hold | 1,100 | $184.71 | $203K | — | — |
| ALT - Altimmune | 0.00% | Hold | 27,600 | $7.21 | $199K | — | — |
| ELAN - Elanco Animal Health | 0.00% | Hold | 16,000 | $12.11 | $194K | — | — |
| IOVA - Iovance Biotrapeutics | 0.00% | Hold | 26,000 | $7.40 | $192K | — | — |
| EVH - Evolent Health · CL A | 0.00% | Reduce −97.8% | 14,000 | $11.25 | $158K | −625,000 | −$18M |
| GERN - Geron | 0.00% | Hold | 43,000 | $3.54 | $152K | — | — |
| AM6 - Amicus Therapeutics | 0.00% | Hold | 16,000 | $9.42 | $151K | — | — |
| OSCR - Oscar Health · CL A | 0.00% | Hold | 11,000 | $13.44 | $148K | — | — |
| COGT - Cogent Biosciences | 0.00% | Hold | 17,000 | $7.80 | $133K | — | — |
| SNDX - Syndax Pharmaceuticals | 0.00% | Hold | 10,000 | $13.22 | $132K | — | — |
| NVAX - Novavax | 0.00% | Hold | 16,000 | $8.04 | $129K | — | — |
| ARDX - Ardelyx | 0.00% | Hold | 23,000 | $5.07 | $117K | — | — |
| CCCC - C4 Therapeutics | 0.00% | Hold | 28,000 | $3.60 | $101K | — | — |
| CGC - Canopy Growth | 0.00% | Hold | 30,000 | $2.74 | $82K | — | — |
| IRWD - Ironwood Pharmaceuticals · CL A | 0.00% | Hold | 13,000 | $4.43 | $58K | — | — |
Showing top 50 of 120 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2024 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| NOW - Servicenow | 1.29% | Exit | 0 | $894.39 | $264M | −295,050 | −$264M |
| SPGI - S&P Global | 1.20% | Exit | 0 | $516.62 | $246M | −475,334 | −$246M |
| SHW - Sherwin Williams | 1.04% | Exit | 0 | $381.67 | $212M | −555,950 | −$212M |
| Stericycle | 0.94% | Exit | 0 | $61.00 | $192M | −3,146,000 | −$192M |
| Southwestern Energy | 0.90% | Exit | 0 | $7.11 | $185M | −25,993,099 | −$185M |
| HWM - Howmet Aerospace | 0.74% | Exit | 0 | $100.25 | $152M | −1,514,339 | −$152M |
| Squarespace · CLASS A | 0.66% | Exit | 0 | $46.43 | $134M | −2,891,632 | −$134M |
| THC - Tenet Healthcare | 0.56% | Exit | 0 | $166.20 | $115M | −692,442 | −$115M |
| Holding | 0.51% | Exit | 0 | $33.33 | $105M | −3,150,857 | −$105M |
| BEKE - KE | 0.46% | Exit | 0 | $19.91 | $94M | −4,740,833 | −$94M |
| LBRDA - Liberty Broadband | 0.25% | Exit | 0 | $77.29 | $51M | −660,000 | −$51M |
| CNC - Centene Del | 0.23% | Exit | 0 | $75.28 | $46M | −614,917 | −$46M |
| TAL - Tal Education Group | 0.08% | Exit | 0 | $11.84 | $16M | −1,365,000 | −$16M |
| AMGN - Amgen | 0.07% | Exit | 0 | $322.21 | $15M | −47,000 | −$15M |
| Ventyx Biosciences | 0.03% | Exit | 0 | $2.18 | $7M | −3,170,000 | −$7M |
| TMDX - Transmedics Group | 0.03% | Exit | 0 | $157.00 | $7M | −44,000 | −$7M |
| ANAB - Anaptysbio | 0.03% | Exit | 0 | $33.50 | $6M | −183,876 | −$6M |
| CYTK - Cytokinetics | 0.03% | Exit | 0 | $52.80 | $5M | −102,400 | −$5M |
| AMLX - Amylyx Pharmaceuticals | 0.02% | Exit | 0 | $3.24 | $4M | −1,150,221 | −$4M |
| Swiftmerge Acquisition · CLASS A | 0.02% | Exit | 0 | $11.04 | $3M | −300,000 | −$3M |
| PCVX - Vaxcyte | 0.02% | Exit | 0 | $114.29 | $3M | −28,000 | −$3M |
| Metagenomi | 0.01% | Exit | 0 | $2.17 | $2M | −1,057,201 | −$2M |
| Cara Therapeutics | — | Exit | 0 | $0.3078 | $479K | −1,556,251 | −$479K |
| RNAGBP - Avidity Biosciences | — | Exit | 0 | $46.00 | $230K | −5,000 | −$230K |
| R1 Rcm | — | Exit | 0 | $14.19 | $227K | −16,000 | −$227K |
| RARE — | — | Exit | 0 | $55.50 | $222K | −4,000 | −$222K |
| ASND - Ascendis Pharma A/S | — | Exit | 0 | $149.29 | $209K | −1,400 | −$209K |
| BYND - Beyond Meat | — | Exit | 0 | $6.79 | $129K | −19,000 | −$129K |
| Lufax | — | Exit | 0 | $3.47 | $52K | −15,000 | −$52K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2